Spyre Therapeutics Inc (SYRE)

Investing Cash Flow

-$463.74M

TTM · Period ending: · USD

SYRE logo

SYRE Investing Cash Flow

Latest reported-$463.74M
SYRE TTM Cash from Investing (-$221.00K → -$463.74M)
High-resolution chart · PNG

SYRE investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Spyre Therapeutics Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-463,735,000
-86,833,000
-143,475,000
-66,609,000
-48,867,000
-248,383,000
-353,285,000
-218,013,000
-358,384,000
-231,106,000
-108,393,000
-59,121,000
55,009,000
48,999,000
57,008,000
52,671,000
41,949,000
-6,160,000
-22,619,000
-3,662,000
-3,655,000
-13,057,000
-7,604,000
-25,898,000
-15,670,000
-922,000
-1,739,000
-14,197,000
-28,810,000
-5,997,000
-15,231,000
-8,255,000
-15,940,000
7,784,000
-22,529,000
-24,814,000
-33,823,000
-36,495,000
-12,076,000
-15,145,000
-3,310,000
-5,186,000
-4,014,000
-3,615,000
-228,000
-209,000
-221,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.